Glenmark Pharmaceuticals Ltd. announced that Mr. Natvarlal B. Desai, Director of the company has resigned from the board to be effective from June 1, 2015.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,237 INR | +1.00% | +3.60% | +44.87% |
Jun. 12 | India Equities Close Higher Ahead of US Inflation Data | MT |
Jun. 12 | Glenmark Pharmaceuticals Gets US FDA Final Nod for Esomeprazole Magnesium Capsules | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+44.87% | 4.18B | |
+20.37% | 43.54B | |
+19.32% | 21.78B | |
+17.85% | 15.38B | |
+25.55% | 15.12B | |
+60.99% | 13.36B | |
-0.05% | 6.79B | |
-15.06% | 6.38B | |
-8.87% | 5.73B | |
+8.17% | 5.32B |
- Stock Market
- Equities
- GLENMARK Stock
- News Glenmark Pharmaceuticals Limited
- Glenmark Pharmaceuticals Ltd. Announces Resignation of Natvarlal B. Desai from the Board to be Effective from June 1, 2015